Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at HCC's multiple
$3.960.7% below market
0.94 ZNTL revenue / share×4.21x HCC P/S=$3.96
Market $3.99Implied $3.96
HCC · current priceP/S 4.21x
$104.45Latest market snapshot
Implied fair value · at ZNTL's multiple
$105.230.7% above market
24.81 HCC revenue / share×4.24x ZNTL P/S=$105.23
Market $104.45Implied $105.23